From: Prognostic marker CD27 and its micro-environmental in multiple myeloma
Risk factor | Univariate analysis HR 95%CI P value | Multivariate analysis HR 95%CI P value |
---|---|---|
ISS stage III | 2.048 1.003–4.182 0.049 | 1.046 0.438–2.501 0.919 |
Cr ≥ 115 μmol/L | 0.934 0.468–1.866 0.848 | |
CD27 + T ≥ 20% | 3.542 1.487–8.436 0.004 | 3.353 1.322–8.504 0.011 |
BMPC ≥ 31.49% | 2.214 1.141–4.297 0.019 | 1.501 0.729–3.090 0.270 |
Ca ≥ 2.75mmlo/L | 0.918 0.398–2.119 0.842 | |
HB < 100 g/L | 1.561 0.280–1.123 0.103 | |
LDH > 246U/L | 0.770 0.401–1.480 0.434 | |
ALB < 35 g/L | 1.903 0.973–3.722 0.060 | |
Age ≥ 65 | 2.336 1.186–4.601 0.014 | 2.426 1.038–5.670 0.041 |
β2-MG ≥ 3.5 μmol/L | 1.889 0.943–3.783 0.073 | |
Therapeutic schemes | 1.617 0.316–1.205 0.158 |